Skip to main content
Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
40.89
+0.08 (0.20%)
At close: Apr 28, 2026, 4:00 PM EDT
40.81
-0.08 (-0.20%)
Pre-market: Apr 29, 2026, 7:54 AM EDT

Travere Therapeutics Revenue

In the year 2025, Travere Therapeutics had annual revenue of $490.73M with 110.45% growth. Travere Therapeutics had revenue of $129.69M in the quarter ending December 31, 2025, with 73.41% growth.

Revenue (ttm)
$490.73M
Revenue Growth
+110.45%
P/S Ratio
7.70
Revenue / Employee
$987,380
Employees
497
Market Cap
3.78B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025490.73M257.55M110.45%
Dec 31, 2024233.18M87.94M60.55%
Dec 31, 2023145.24M35.78M32.69%
Dec 31, 2022109.46M-22.38M-16.97%
Dec 31, 2021131.84M-66.49M-33.52%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ACADIA Pharmaceuticals 1.07B
Legend Biotech 1.03B
Telix Pharmaceuticals 803.79M
Catalyst Pharmaceuticals 588.99M
Tango Therapeutics 62.38M
NewAmsterdam Pharma Company 22.50M
Crinetics Pharmaceuticals 7.70M
Revenue Rankings

TVTX News

More News